EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optical Coherence Tomography Angiography Findings in Primary Progressive Multiple Sclerosis Patients Receiving Ocrelizumab Treatment

Burçin Çakır iD, Seren Kaplan Güngördü iD, Nilgün Özkan Aksoy, Dilcan Kotan

Diagnostics · 22.03.2026 · 16 (6) · 936

DOI: 10.3390/diagnostics16060936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 22.03.2026. Verfasst von Burçin Çakır und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Sakarya University, Sakarya 54187, Turkey. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to evaluate macular vessel area densities (superficial and deep) and foveal avascular zone (FAZ) measurements using OCT-A in the eyes of primary progressive multiple sclerosis (PPMS) patients receiving Ocrelizumab treatment with or without optic nerve involvement.

Methods

The medical records of PPMS patients who received Ocrelizumab treatment at least once were reviewed. Retinal nerve fiber layer (RNFL) thickness measurements and OCT-A analysis were conducted on the PPMS patients and on age-matched healthy individuals. The patient group was divided into two subgroups: eyes with optic neuritis (PPMS+ON) and eyes without ON (PPMS-ON). Central and mean superficial vessel area (SVA) and deep vessel area (DVA) densities, as well as foveal avascular zone (FAZ) measurements, were analyzed. All parameters were statistically compared between groups and subgroups.

Results

A total of 38 PPMS patients receiving Ocrelizumab treatment and 31 healthy individuals were included in this study. Statistically significant differences were observed between the groups in terms of best corrected visual acuity (BCVA), RNFL thickness, and the superficial vessel area densities for all parts except for the central part. In terms of deep vessel area densities, differences were found in the central and inferior parts. The mean FAZ area also showed a statistically significant difference between groups. Mean RNFL thickness differed significantly between the subgroups. Mean nasal, temporal, inferior part, and total superficial vessel area densities were statistically different between the subgroups. The central and inferior parts of the deep vessel area densities showed statistically significant differences. The mean FAZ area was also statistically different between the subgroups.

Conclusions

The findings suggest that macular superficial and deep vascular densities are affected in PPMS patients receiving the same therapy modality and that previous optic neuritis may influence the results.

Schlagwörter

Stichwörter der Autor:innen

macular vascular densityoptic neuritisprimary progressive multiple sclerosisretinal nerve fiber layer thickness

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, Sakarya University, Sakarya 54187, Turkey.
  • Department of Neurology, Faculty of Medicine, Sakarya University, Sakarya 54187, Turkey.

ORCID-Profile: Burçin Çakır, Seren Kaplan Güngördü

Zitieren

APA

Çakır, B., Kaplan Güngördü, S., Özkan Aksoy, N., & Kotan, D. (2026). Optical Coherence Tomography Angiography Findings in Primary Progressive Multiple Sclerosis Patients Receiving Ocrelizumab Treatment. Diagnostics, 16(6), 936. https://doi.org/10.3390/diagnostics16060936

Vancouver

Çakır B, Kaplan Güngördü S, Özkan Aksoy N, Kotan D. Optical Coherence Tomography Angiography Findings in Primary Progressive Multiple Sclerosis Patients Receiving Ocrelizumab Treatment. Diagnostics. 2026;16(6):936. doi:10.3390/diagnostics16060936

BibTeX
@article{akr2026,
  author = {Çakır, Burçin and Kaplan Güngördü, Seren and Özkan Aksoy, Nilgün and Kotan, Dilcan},
  title = {Optical Coherence Tomography Angiography Findings in Primary Progressive Multiple Sclerosis Patients Receiving Ocrelizumab Treatment},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {936},
  doi = {10.3390/diagnostics16060936}
}
Kostenlos starten →